SCHEMBL17240231

SCHEMBL17240231

[CH2]C(c1cnc(C)nc1)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17240250 0.77
SCHEMBL27707801 0.71 EDNRA (0.31)
SCHEMBL27778404 0.71 SMN1; SMN2 (0.39)
SCHEMBL18274469 0.68
SCHEMBL3265716 0.67 LMNA (0.32)
SCHEMBL15797684 0.66 OPRM1 (0.32)
SCHEMBL17103223 0.65 RXRA (0.32)
SCHEMBL17240229 0.64 APLNR (0.32)
SCHEMBL22778736 0.64
SCHEMBL996997 0.64 APLNR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9718774-B2 Indole carboxamide derivatives as P2X7 receptor antagonist IDORSIA PHARMACEUTICALS LTD (CH) 2017-08-01 US disclosed
US-20150322008-A1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONIST ACTELION PHARMACEUTICALS LTD (CH) 2015-11-12 US disclosed